Liaoning Chengda Biotechnology Co.,Ltd. (SHA:688739)

Market Cap	11.40B
Revenue (ttm)	1.67B
Net Income (ttm)	333.58M
Shares Out	411.64M
EPS (ttm)	0.81
PE Ratio	34.16
Forward PE	28.84
Dividend	0.80 (2.89%)
Ex-Dividend Date	Jun 10, 2025

Volume	1,589,850
Average Volume	2,374,426
Open	27.81
Previous Close	27.90
Day's Range	27.59 - 27.93
52-Week Range	21.95 - 33.15
Beta	0.71
RSI	72.01
Earnings Date	Aug 29, 2025

About SHA:688739

Liaoning Chengda Biotechnology Co.,Ltd. a biotechnology company, engages in the research and development, production, and sales of vaccines for human use in China. It offers Chengda Suda human rabies and Chengda Libao Human Type B inactivated encephalitis vaccines. The company also exports its products to 32 countries including India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, and other countries. Liaoning Chengda Biotechnology Co.,Ltd. was founded in 2002 and is headquartered in Shenyang, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 1,807
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688739

Financial Performance

In 2024, SHA:688739's revenue was 1.68 billion, a decrease of -4.22% compared to the previous year's 1.75 billion. Earnings were 342.82 million, a decrease of -26.42%.